These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

212 related items for PubMed ID: 6088836

  • 21. [Essential thrombocythemia in transformation to acute leukemia (FAB-M0) as a natural history from myelofibrosis with t(1;7)].
    Hayashi S, Iwama H, Uchida Y, Kawakubo K, Inatomi Y, Nagasu M, Miyazawa K, Ohyashiki JH, Ohyashiki K, Toyama K.
    Rinsho Ketsueki; 1997 May; 38(5):445-7. PubMed ID: 9194391
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Recent advances in the study of megakaryocytic leukemia.
    Shibata A.
    Nihon Ketsueki Gakkai Zasshi; 1985 Dec; 48(8):1743-52. PubMed ID: 3915407
    [No Abstract] [Full Text] [Related]

  • 24. [An acute leukemia case with complex karyotype abnormalities and marked thrombocythemia].
    Okamura T, Hayakawa H, Sumida I, Hanada M, Nakasato S, Takeshita M, Ohgami A, Kikuchi M, Kamada N.
    Rinsho Ketsueki; 1987 Nov; 28(11):2023-8. PubMed ID: 3482113
    [No Abstract] [Full Text] [Related]

  • 25. [An autopsy case of myelofibrosis with myeloid metaplasia terminating in blastic transformation with chromosomal aberration (i(17q))].
    Nakamura H, Yamada Y, Sadamori N, Yao E, Tagawa M, Nishino K, Kamihira S, Oyakawa Y, Tomonaga M, Ichimaru M.
    Rinsho Ketsueki; 1984 Jun; 25(6):864-9. PubMed ID: 6481978
    [No Abstract] [Full Text] [Related]

  • 26. [Megakaryoblastic transformation in polycythemia vera--a case of megakaryoblastic leukemia associated with myelofibrosis and elevation of serum PDGF-like activity].
    Oda K, Katoh O, Kawano M, Iwato K, Kimura A, Imamura N, Fujimura K, Kuramoto A, Yasui W, Kajihara H.
    Rinsho Ketsueki; 1986 Nov; 27(11):2118-23. PubMed ID: 3820629
    [No Abstract] [Full Text] [Related]

  • 27. Post-essential thrombocythemia myelofibrosis and chronic myelomonocytic leukemia can co-exist with complex cytogenetic abnormalities.
    Trakhtenbrot L, Tohami T, Schiby G, Kneller A, Rosenthal E, Rosner E, Amariglio N, Salomon O.
    Leuk Res; 2010 Nov; 34(11):e308-10. PubMed ID: 20655587
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. [Malignant proliferations of the megakaryocyte and acute megakaryoblastic leukemia].
    Duhamel G.
    Ann Med Interne (Paris); 1981 Nov; 132(1):1-2. PubMed ID: 7194616
    [No Abstract] [Full Text] [Related]

  • 30. Myeloproliferative disorders terminating in acute megakaryoblastic leukemia with chromosome 3q26 abnormality.
    Akahoshi M, Oshimi K, Mizoguchi H, Okada M, Enomoto Y, Watanabe Y.
    Cancer; 1987 Dec 01; 60(11):2654-61. PubMed ID: 3479228
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Platelet count predicts driver mutations' co-occurrence in low JAK2 mutated essential thrombocythemia and myelofibrosis.
    Mora B, Siracusa C, Rumi E, Maffioli M, Casetti IC, Barraco D, Merli M, Rossi M, Ubezio M, Accetta R, Libera L, Pietra D, Trotti C, Uccella S, Pallotti F, Casalone R, Bertù L, Arcaini L, Della Porta MG, Passamonti F.
    Leukemia; 2021 May 01; 35(5):1490-1493. PubMed ID: 33051550
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Long-term follow-up of a patient with idiopathic myelofibrosis associated with chromosome 11 and 13 abnormalities.
    Toubai T, Tanaka J, Higa T, Ota S, Ibata M, Shono Y, Mashiko S, Miura Y, Umehara S, Kahata K, Toyoshima N, Morioka M, Asaka M, Kasai M, Imamura M.
    Am J Hematol; 2005 Jan 01; 78(1):67-70. PubMed ID: 15609290
    [Abstract] [Full Text] [Related]

  • 36. Philadelphia (Ph) chromosome-positive thrombocythemia without features of chronic myeloid leukemia in peripheral blood: natural history and diagnostic differentiation from Ph-negative essential thrombocythemia.
    Michiels JJ, Berneman Z, Schroyens W, Kutti J, Swolin B, Ridell B, Fernando P, Zanetto U.
    Ann Hematol; 2004 Aug 01; 83(8):504-12. PubMed ID: 15164229
    [Abstract] [Full Text] [Related]

  • 37. Abnormal clones of megakaryocytes in myeloproliferative disorders.
    Sato Y, Suda T.
    Nihon Ketsueki Gakkai Zasshi; 1986 Dec 01; 49(8):1705-18. PubMed ID: 3471029
    [No Abstract] [Full Text] [Related]

  • 38. Different immunophenotypical apoptotic profiles characterise megakaryocytes of essential thrombocythaemia and primary myelofibrosis.
    Florena AM, Tripodo C, Di Bernardo A, Iannitto E, Guarnotta C, Porcasi R, Ingrao S, Abbadessa V, Franco V.
    J Clin Pathol; 2009 Apr 01; 62(4):331-8. PubMed ID: 19329711
    [Abstract] [Full Text] [Related]

  • 39. MicroRNA expression profiling of megakaryocytes in primary myelofibrosis and essential thrombocythemia.
    Hussein K, Theophile K, Dralle W, Wiese B, Kreipe H, Bock O.
    Platelets; 2009 Sep 01; 20(6):391-400. PubMed ID: 19811223
    [Abstract] [Full Text] [Related]

  • 40. Criteria for the diagnosis of acute leukemia of megakaryocyte lineage (M7). A report of the French-American-British Cooperative Group.
    Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton DA, Gralnick HR, Sultan C.
    Ann Intern Med; 1985 Sep 01; 103(3):460-2. PubMed ID: 2411180
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.